Andrew L. Darrow

2.9k total citations
32 papers, 2.5k citations indexed

About

Andrew L. Darrow is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Andrew L. Darrow has authored 32 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Hematology and 12 papers in Cancer Research. Recurrent topics in Andrew L. Darrow's work include Blood Coagulation and Thrombosis Mechanisms (15 papers), Protease and Inhibitor Mechanisms (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Andrew L. Darrow is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (15 papers), Protease and Inhibitor Mechanisms (12 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Andrew L. Darrow collaborates with scholars based in United States, Australia and Switzerland. Andrew L. Darrow's co-authors include Sidney Strickland, Patricia Andrade‐Gordon, Claudia K. Derian, Richard J. Rickles, Rosemary J. Santulli, Michael R. D’Andrea, Bruce P. Damiano, M. O'Connell, Annette Eckardt and Marylyn M. Addo and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Andrew L. Darrow

32 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew L. Darrow United States	25	1.2k	1.0k	633	573	336	32	2.5k
Valeria Ossovskaya United States	18	663 0.5×	1.1k 1.1×	395 0.6×	487 0.8×	112 0.3×	31	2.4k
Anika Agarwal United States	21	565 0.5×	965 1.0×	248 0.4×	643 1.1×	110 0.3×	26	2.3k
Stany Chrétien France	29	873 0.7×	1.9k 1.9×	506 0.8×	277 0.5×	83 0.2×	64	3.4k
Andrew J. Leger United States	14	546 0.4×	827 0.8×	268 0.4×	308 0.5×	295 0.9×	16	1.6k
Karen L. Wion United Kingdom	10	1.5k 1.2×	1.3k 1.3×	389 0.6×	115 0.2×	264 0.8×	10	2.7k
Amittha Wickrema United States	38	1.6k 1.3×	1.8k 1.7×	740 1.2×	273 0.5×	76 0.2×	111	3.9k
Suzanne E. Williams United States	12	355 0.3×	807 0.8×	82 0.1×	651 1.1×	164 0.5×	18	1.9k
Yuka Nagata Japan	21	460 0.4×	702 0.7×	203 0.3×	120 0.2×	87 0.3×	48	1.6k
Rebecca J. Chan United States	32	580 0.5×	2.2k 2.2×	349 0.6×	219 0.4×	67 0.2×	90	3.3k
A. Robert MacLeod United States	29	436 0.4×	2.9k 2.9×	583 0.9×	2.0k 3.4×	238 0.7×	57	4.0k

Countries citing papers authored by Andrew L. Darrow

Since Specialization

Citations

This map shows the geographic impact of Andrew L. Darrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew L. Darrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew L. Darrow more than expected).

Fields of papers citing papers by Andrew L. Darrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew L. Darrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew L. Darrow. The network helps show where Andrew L. Darrow may publish in the future.

Co-authorship network of co-authors of Andrew L. Darrow

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew L. Darrow. A scholar is included among the top collaborators of Andrew L. Darrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew L. Darrow. Andrew L. Darrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greco, Michael N., Margery A. Connelly, Gregory C. Leo, et al.. (2013). A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice. Bioorganic & Medicinal Chemistry Letters. 23(9). 2595–2597. 5 indexed citations

Darrow, Andrew L., Matthew W. Olson, Xin Hong, et al.. (2010). A novel fluorogenic substrate for the measurement of endothelial lipase activity. Journal of Lipid Research. 52(2). 374–382. 22 indexed citations

Qi, Jenson, Wensheng Lang, Edward C. Giardino, et al.. (2010). High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity. Journal of Lipid Research. 51(12). 3559–3567. 21 indexed citations

Leo, Gregory C. & Andrew L. Darrow. (2009). NMR‐based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein‐E deficient mice. Magnetic Resonance in Chemistry. 47(S1). S20–5. 21 indexed citations

Ilyin, Sergey E., Daniel Horowitz, Stanley M. Belkowski, et al.. (2005). Integrated expressional analysis: Application to the drug discovery process. Methods. 37(3). 280–288. 11 indexed citations

Roberts, Jane L., Paul A.B. Moretti, Andrew L. Darrow, et al.. (2004). An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes. Analytical Biochemistry. 331(1). 122–129. 32 indexed citations

Roberts, Jeanette C., Paul A.B. Moretti, Andrew L. Darrow, et al.. (2004). An assay for sphingosine kinase activity using biotinylated sphingosine and streptavidin-coated membranes. Analytical Biochemistry. 331(1). 122–129. 25 indexed citations

Derian, Claudia K., Bruce P. Damiano, Marylyn M. Addo, et al.. (2003). Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 304(2). 855–861. 123 indexed citations

Darrow, Andrew L., Kelly A. Conway, Anil H. Vaidya, et al.. (2003). Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening. SLAS DISCOVERY. 8(1). 65–71. 8 indexed citations

10.

Sabri, Abdelkarim, Jianfen Guo, Hasnae Elouardighi, et al.. (2003). Mechanisms of Protease-activated Receptor-4 Actions in Cardiomyocytes. Journal of Biological Chemistry. 278(13). 11714–11720. 66 indexed citations

11.

Pitson, Stuart M., Paul A.B. Moretti, Julia R. Zebol, et al.. (2002). The Nucleotide-binding Site of Human Sphingosine Kinase 1. Journal of Biological Chemistry. 277(51). 49545–49553. 90 indexed citations

12.

Maryanoff, Bruce E., Rosemary J. Santulli, David F. McComsey, et al.. (2001). Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes. Archives of Biochemistry and Biophysics. 386(2). 195–204. 47 indexed citations

13.

Damiano, Bruce P., Rosemary J. Santulli, Wai‐Ping Fung‐Leung, et al.. (1999). Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1. Journal of Pharmacology and Experimental Therapeutics. 288(2). 671–678. 165 indexed citations

14.

Andrade‐Gordon, Patricia, Bruce E. Maryanoff, Claudia K. Derian, et al.. (1999). Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proceedings of the National Academy of Sciences. 96(22). 12257–12262. 153 indexed citations

15.

Smith‐Swintosky, Virginia L., et al.. (1997). Protease‐Activated Receptor‐2 (PAR‐2) Is Present in the Rat Hippocampus and Is Associated with Neurodegeneration. Journal of Neurochemistry. 69(5). 1890–1896. 93 indexed citations

16.

Carroll, Pamela M., William G. Richards, Andrew L. Darrow, James M. Wells, & Sidney Strickland. (1993). Preimplantation mouse embryos express a cell surface receptor for tissue-plasminogen activator. Development. 119(1). 191–198. 28 indexed citations

17.

Huarte, J, André Stutz, M. O'Connell, et al.. (1992). Transient translational silencing by reversible mRNA deadenylation. Cell. 69(6). 1021–1030. 200 indexed citations

18.

Darrow, Andrew L., Richard J. Rickles, Lauren Pecorino, & Sidney Strickland. (1990). Transcription Factor Sp1 Is Important for Retinoic Acid-Induced Expression of the Tissue Plasminogen Activator Gene during F9 Teratocarcinoma Cell Differentiation. Molecular and Cellular Biology. 10(11). 5883–5893. 5 indexed citations

19.

Darrow, Andrew L., Richard J. Rickles, & Sidney Strickland. (1990). Maintenance and use of F9 teratocarcinoma cells. Methods in enzymology on CD-ROM/Methods in enzymology. 190. 110–117. 34 indexed citations

20.

Darrow, Andrew L., Richard J. Rickles, Lauren Pecorino, & Sidney Strickland. (1990). Transcription factor Sp1 is important for retinoic acid-induced expression of the tissue plasminogen activator gene during F9 teratocarcinoma cell differentiation.. Molecular and Cellular Biology. 10(11). 5883–5893. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact